Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study Academic Article uri icon

Overview

MeSH Major

  • Arthritis, Juvenile
  • Immunosuppressive Agents
  • Thalidomide

abstract

  • Thirteen children with difficult systemic onset juvenile rheumatoid arthritis were treated with thalidomide. At 6 months, 11 of the 13 were able to reduce their use of prednisone ( P < .002), with a concurrent improvement in erythrocyte sedimentation rate ( P < .0001) and an increase in hemoglobin level ( P < 0.005). Juvenile rheumatoid arthritis improvement scores >/=50% were obtained by 10 of the 13 children.

publication date

  • December 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jpeds.2004.08.020

PubMed ID

  • 15580219

Additional Document Info

start page

  • 856

end page

  • 7

volume

  • 145

number

  • 6